Report Detail
Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Growth 2019-2024
- RnM3216057 |
- 30 March, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Nosocomial or hospital acquired infections have created numerous complications for patients in hospitals throughout the world, as these infections are caused by multidrug resistant microorganisms, the recuperation of a patient is drastically reduced and accompanied by several comorbidities. Being multidrug resistant, these organisms are immune to the conventional antibiotics hence difficult to treat. Pneumonia is one of the prominent infections caused in hospital premises. Cases of hospital acquired pneumonia are common in immunocompromised patients, post surgical infections, enteral feeding, elderly and infant patients. As hospital acquired pneumonia is mainly caused as a result of prolonged exposure to ventilator air, it is also called as ventilator associated pneumonia. Major causative pathogens include methicillin resistant S. aureus (MRSA), multi drug resistant (MDR) P. aeruginosa, Klebsiella and Acinetobacter. Respiratory Syncytial Virus (RSV) has also been found to be a major causative agent of nosocomial pneumonia in new borne.
According to this study, over the next five years the Pipeline Analysis of Hospital Acquired Pneumonia Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pipeline Analysis of Hospital Acquired Pneumonia Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pipeline Analysis of Hospital Acquired Pneumonia Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Pipeline Analysis of Hospital Acquired Pneumonia Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tedizolid Phosphate
Ceftolozane/Tazobactam
Ceftazidime/Avibactum
Amikacin Inhale
Plazomicin
Synflorix Vaccine
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Bacterial Pneumonia
Viral Pneumonia
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Achaogen
Aridis Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
Meiji Seika Pharma
Merck
Sanofi
GlaxoSmithKline
Valneva
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pipeline Analysis of Hospital Acquired Pneumonia Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pipeline Analysis of Hospital Acquired Pneumonia Drugs market by identifying its various subsegments.
Focuses on the key global Pipeline Analysis of Hospital Acquired Pneumonia Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pipeline Analysis of Hospital Acquired Pneumonia Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pipeline Analysis of Hospital Acquired Pneumonia Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption 2014-2024
- 2.1.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption CAGR by Region
- 2.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Segment by Type
- 2.2.1 Tedizolid Phosphate
- 2.2.2 Ceftolozane/Tazobactam
- 2.2.3 Ceftazidime/Avibactum
- 2.2.4 Amikacin Inhale
- 2.2.5 Plazomicin
- 2.2.6 Synflorix Vaccine
- 2.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Type
- 2.3.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sale Price by Type (2014-2019)
- 2.4 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Segment by Application
- 2.4.1 Bacterial Pneumonia
- 2.4.2 Viral Pneumonia
- 2.5 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Application
- 2.5.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sale Price by Application (2014-2019)
3 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Players
- 3.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Players
- 3.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales by Players (2017-2019)
- 3.1.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Players
- 3.2.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sale Price by Players
- 3.4 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Pipeline Analysis of Hospital Acquired Pneumonia Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Regions
- 4.1 Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Regions
- 4.1.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Regions
- 4.1.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value by Regions
- 4.2 Americas Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Growth
- 4.3 APAC Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Growth
- 4.4 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Growth
- 4.5 Middle East & Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Growth
5 Americas
- 5.1 Americas Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Countries
- 5.1.1 Americas Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value by Countries (2014-2019)
- 5.2 Americas Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Type
- 5.3 Americas Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Countries
- 6.1.1 APAC Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value by Countries (2014-2019)
- 6.2 APAC Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Type
- 6.3 APAC Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Countries
- 7.1.1 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value by Countries (2014-2019)
- 7.2 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Type
- 7.3 Europe Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs by Countries
- 8.1.1 Middle East & Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Type
- 8.3 Middle East & Africa Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Distributors
- 10.3 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Customer
11 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Forecast
- 11.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Consumption Forecast (2019-2024)
- 11.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast by Regions
- 11.2.1 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast by Type
- 11.8 Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Achaogen
- 12.1.1 Company Details
- 12.1.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.1.3 Achaogen Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Achaogen News
- 12.2 Aridis Pharmaceuticals
- 12.2.1 Company Details
- 12.2.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.2.3 Aridis Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Aridis Pharmaceuticals News
- 12.3 AstraZeneca
- 12.3.1 Company Details
- 12.3.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.3.3 AstraZeneca Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 AstraZeneca News
- 12.4 Cubist Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.4.3 Cubist Pharmaceuticals Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Cubist Pharmaceuticals News
- 12.5 Meiji Seika Pharma
- 12.5.1 Company Details
- 12.5.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.5.3 Meiji Seika Pharma Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Meiji Seika Pharma News
- 12.6 Merck
- 12.6.1 Company Details
- 12.6.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.6.3 Merck Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Merck News
- 12.7 Sanofi
- 12.7.1 Company Details
- 12.7.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.7.3 Sanofi Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Sanofi News
- 12.8 GlaxoSmithKline
- 12.8.1 Company Details
- 12.8.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.8.3 GlaxoSmithKline Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 GlaxoSmithKline News
- 12.9 Valneva
- 12.9.1 Company Details
- 12.9.2 Pipeline Analysis of Hospital Acquired Pneumonia Drugs Product Offered
- 12.9.3 Valneva Pipeline Analysis of Hospital Acquired Pneumonia Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Valneva News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pipeline Analysis of Hospital Acquired Pneumonia Drugs . Industry analysis & Market Report on Pipeline Analysis of Hospital Acquired Pneumonia Drugs is a syndicated market report, published as Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pipeline Analysis of Hospital Acquired Pneumonia Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
